REFERENCES
1. World Health Organization (WHO). Tobacco. 2025. https://www.who.int/news-room/fact-sheets/detail/tobacco. (accessed 2026-02-11).
2. Goniewicz, M. L.; Gawron, M.; Smith, D. M.; Peng, M.; Jacob, P. 3rd; Benowitz, N. L. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine. Tob. Res. 2017, 19, 160-7.
3. Yayan, J.; Franke, K. J.; Biancosino, C.; Rasche, K. Comparative systematic review on the safety of e-cigarettes and conventional cigarettes. Food. Chem. Toxicol. 2024, 185, 114507.
4. Scherer, G. Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: a literature review. Regul. Toxicol. Pharmacol. 2018, 94, 203-33.
5. Benowitz, N. L.; Bernert, J. T.; Foulds, J.; et al. Biochemical verification of tobacco use and abstinence: 2019 update. Nicotine. Tob. Res. 2020, 22, 1086-97.
6. Pluym, N.; Burkhardt, T.; Scherer, G.; Scherer, M. The potential of new nicotine and tobacco products as tools for people who smoke to quit combustible cigarettes - a systematic review of common practices and guidance towards a robust study protocol to measure cessation efficacy. Harm. Reduct. J. 2024, 21, 130.
7. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine. Tob. Res. 2002, 4, 149-59.
8. CORESTA Guides. No. 29 - Best practice in the application of biomarkers of exposure as compliance measures in long-term and epidemiological studies of new nicotine and tobacco products. 2024. https://www.coresta.org/best-practice-application-biomarkers-exposure-compliance-measures-long-term-and-epidemiological. (accessed 2026-02-11).
9. Feng, J.; Sosnoff, C. S.; Bernert, J. T.; et al. Urinary nicotine metabolites and self-reported tobacco use among adults in the population assessment of tobacco and health (PATH) study, 2013-2014. Nicotine. Tob. Res. 2022, 24, 768-77.
10. Wang, Z.; Zheng, Q.; Tscharke, B. J.; et al. High throughput and sensitive quantitation of tobacco-specific alkaloids and nitrosamines in wastewater. Talanta 2024, 277, 126401.
11. Goniewicz, M. L.; Havel, C. M.; Peng, M. W.; et al. Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Cancer. Epidemiol. Biomarkers. Prev. 2009, 18, 3421-5.
12. Bhandari, D.; Zhang, L.; Zhu, W.; De Jesús, V. R.; Blount, B. C. Optimal cutoff concentration of urinary cyanoethyl mercapturic acid for differentiating cigarette smokers from nonsmokers. Nicotine. Tob. Res. 2022, 24, 761-7.
13. Jakubowski, M.; Linhart, I.; Pielas, G.; Kopecký, J. 2-Cyanoethylmercapturic acid (CEMA) in the urine as a possible indicator of exposure to acrylonitrile. Br. J. Ind. Med. 1987, 44, 834-40.
14. Burkhardt, T.; Pluym, N.; Scherer, G.; Scherer, M. 1,2-Propylene glycol: a biomarker of exposure specific to e-cigarette consumption. Separations 2021, 8, 180.
15. Hiler, M.; Breland, A.; Wolf, C. E.; Poklis, J. L.; Nanco, C. R.; Eissenberg, T. Are urine propylene glycol or vegetable glycerin markers of e-cigarette use or abstinence? Tob. Regul. Sci. 2020, 6, 235-41.
16. Yu, D. K.; Elmquist, W. F.; Sawchuk, R. J. Pharmacokinetics of propylene glycol in humans during multiple dosing regimens. J. Pharm. Sci. 1985, 74, 876-9.
17. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH guideline M10 on bioanalytical method validation and study sample analysis. 2022. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf. (accessed 2026-02-11).
18. Food and Drug Administration (FDA). Bioanalytical method validation - Guidance for Industry. 2018. https://www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf. (accessed 2026-02-11).
19. Scherer, G.; Mütze, J.; Pluym, N.; Scherer, M. Assessment of nicotine delivery and uptake in users of various tobacco/nicotine products. Curr. Res. Toxicol. 2022, 3, 100067.
20. Scherer, G.; Scherer, M.; Mütze, J.; Hauke, T.; Pluym, N. Assessment of the exposure to tobacco-specific nitrosamines and minor tobacco alkaloids in users of various tobacco/nicotine products. Chem. Res. Toxicol. 2022, 35, 684-93.
21. Pluym, N.; Gilch, G.; Scherer, G.; Scherer, M. Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methods. Anal. Bioanal. Chem. 2015, 407, 5463-76.
22. Scherer, G.; Newland, K.; Papadopoulou, E.; Minet, E. A correlation study applied to biomarkers of internal and effective dose for acrylonitrile and 4-aminobiphenyl in smokers. Biomarkers 2014, 19, 291-301.
23. Jaffé, M. On the precipitation produced by picric acid in normal urine and on a new reaction of creatinine (in Germany). 1886.
24. Benowitz, N. L.; Nardone, N.; Jain, S.; et al. Comparison of urine 4-(methylnitrosamino)-1-(3)pyridyl-1-butanol and cotinine for assessment of active and passive smoke exposure in urban adolescents. Cancer. Epidemiol. Biomarkers. Prev. 2018, 27, 254-61.
25. Bendik, P. B.; Rutt, S. M.; Pine, B. N.; et al. Anabasine and anatabine exposure attributable to cigarette smoking: National Health and Nutrition Examination Survey (NHANES) 2013-2014. Int. J. Environ. Res. Public. Health. 2022, 19, 9744.
26. Tavares, R.; Borba, H.; Monteiro, M.; et al. Monitoring of exposure to acrylonitrile by determination of N-(2-cyanoethyl)valine at the N-terminal position of haemoglobin. Carcinogenesis 1996, 17, 2655-60.
27. Maga, M.; Janik, M. K.; Wachsmann, A.; et al. Influence of air pollution on exhaled carbon monoxide levels in smokers and non-smokers. A prospective cross-sectional study. Environ. Res. 2017, 152, 496-502.
28. Castleden, C. M.; Cole, P. V. Carboxyhaemoglobin levels of smokers and non-smokers working in the City of London. Br. J. Ind. Med. 1975, 32, 115-8.
29. Benowitz, N. L.; Hukkanen, J.; Jacob, P. Nicotine chemistry, metabolism, kinetics and biomarkers. In Nicotine psychopharmacology. Henningfield, J. E.; London, E. D.; Pogun, S.; Eds; Berlin: Springer Berlin Heidelberg, 2009; pp. 29-60.
30. Campo, L.; Polledri, E.; Bechtold, P.; et al. Determinants of active and environmental exposure to tobacco smoke and upper reference value of urinary cotinine in not exposed individuals. Environ. Res. 2016, 148, 154-63.
31. Edwards, K. C.; Naz, T.; Stanton, C. A.; et al. Urinary cotinine and cotinine + trans-3'-hydroxycotinine (TNE-2) cut-points for distinguishing tobacco use from nonuse in the United States: PATH study (2013-2014). Cancer. Epidemiol. Biomarkers. Prev. 2021, 30, 1175-84.
32. Kim, S. Overview of cotinine cutoff values for smoking status classification. Int. J. Environ. Res. Public. Health. 2016, 13, 1236.
33. Paci, E.; Pigini, D.; Bauleo, L.; Ancona, C.; Forastiere, F.; Tranfo, G. Urinary cotinine concentration and self-reported smoking status in 1075 subjects living in central Italy. Int. J. Environ. Res. Public. Health. 2018, 15, 804.
34. Park, E. Y.; Lim, M. K.; Park, E.; Kim, Y.; Lee, D.; Oh, K. Optimum urine cotinine and NNAL levels to distinguish smokers from non-smokers by the changes in tobacco control policy in Korea from 2008 to 2018. Nicotine. Tob. Res. 2022, 24, 1821-8.
35. Piller, M.; Gilch, G.; Scherer, G.; Scherer, M. Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolites. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2014, 951-2, 7-15.
36. CORESTA Reports. Meta-analysis study to establish baseline levels of COHb and NEQs in smokers and non-smokers. 2019. https://www.coresta.org/meta-analysis-study-establish-baseline-levels-cohb-and-neqs-smokers-and-non-smokers-33007.html. (accessed 2026-02-11).
37. Jacob, P. 3rd; Yu, L.; Shulgin, A. T.; Benowitz, N. L. Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am. J. Public. Health. 1999, 89, 731-6.
38. Xia, B.; Blount, B. C.; Guillot, T.; et al. Tobacco-specific nitrosamines (NNAL, NNN, NAT, and NAB) exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014). Nicotine. Tob. Res. 2021, 23, 573-83.
39. Colsoul, M. L.; Goderniaux, N.; Onorati, S.; et al. Novel proposed cutoff values for anatabine and anabasine in differentiating smokers from non-smokers. Clin. Biochem. 2023, 116, 128-31.
40. Suh-Lailam, B. B.; Haglock-Adler, C. J.; Carlisle, H. J.; Ohman, T.; McMillin, G. A. Reference interval determination for anabasine: a biomarker of active tobacco use. J. Anal. Toxicol. 2014, 38, 416-20.
41. Luo, X.; Carmella, S. G.; Chen, M.; et al. Urinary cyanoethyl mercapturic acid, a biomarker of the smoke toxicant acrylonitrile, clearly distinguishes smokers from nonsmokers. Nicotine. Tob. Res. 2020, 22, 1744-7.
42. Camacho, O. M.; Hedge, A.; Lowe, F.; et al. Statistical analysis plan for “A randomised, controlled study to evaluate the effects of switching from cigarette smoking to using a tobacco heating product on health effect indicators in healthy subjects”. Contemp. Clin. Trials. Commun. 2020, 17, 100535.
43. Scherer, G. Carboxyhemoglobin and thiocyanate as biomarkers of exposure to carbon monoxide and hydrogen cyanide in tobacco smoke. Exp. Toxicol. Pathol. 2006, 58, 101-24.
44. Sánchez Fernández, C.; Girón Matute, W. I.; Zichen, J.; et al. Correlation between blood carboxyhemoglobin levels and smoking. Eur. Respir. J. 2022, 60, 3618.
45. Whincup, P.; Papacosta, O.; Lennon, L.; Haines, A. Carboxyhaemoglobin levels and their determinants in older British men. BMC. Public. Health. 2006, 6, 189.
46. Pojer, R.; Whitfield, J. B.; Poulos, V.; Eckhard, I. F.; Richmond, R.; Hensley, W. J. Carboxyhemoglobin, cotinine, and thiocyanate assay compared for distinguishing smokers from non-smokers. Clin. Chem. 1984, 30, 1377-80.
48. Wang, Y.; Wong, L. Y.; Meng, L.; et al. Urinary concentrations of monohydroxylated polycyclic aromatic hydrocarbons in adults from the U.S. Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014). Environ. Int. 2019, 123, 201-8.
49. Li, Z.; Romanoff, L.; Bartell, S.; et al. Excretion profiles and half-lives of ten urinary polycyclic aromatic hydrocarbon metabolites after dietary exposure. Chem. Res. Toxicol. 2012, 25, 1452-61.
